Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Intangibles: 2019-2024

Historic Change in Intangibles for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to $10.0 million.

  • Eton Pharmaceuticals' Change in Intangibles rose 947.74% to $8.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $12.8 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2024, which is 1188.77% up from last year.
  • As of FY2024, Eton Pharmaceuticals' Change in Intangibles stood at $10.0 million, which was up 1,188.77% from $775,000 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Change in Intangibles ranged from a high of $10.0 million in FY2024 and a low of $775,000 during FY2023.
  • For the 3-year period, Eton Pharmaceuticals' Change in Intangibles averaged around $4.5 million, with its median value being $2.8 million (2022).
  • Its Change in Intangibles has fluctuated over the past 5 years, first crashed by 71.82% in 2023, then surged by 1,188.77% in 2024.
  • Yearly analysis of 4 years shows Eton Pharmaceuticals' Change in Intangibles stood at $3.2 million in 2021, then declined by 15.38% to $2.8 million in 2022, then tumbled by 71.82% to $775,000 in 2023, then skyrocketed by 1,188.77% to $10.0 million in 2024.